Healthcare | August 08, 2021
Metropolis Healthcare PAT at Rs 74.89 crores for Q1FY22
Board approves fundraise of Rs 1500 crore
Board approves fundraise of Rs 1500 crore
Forex gains stood at Rs 20 crore for the quarter
India business contributes to a stellar performance
Aditya Puri former MD of HDFC bank joins Solara board as chairman
Nureca Ltd has reported financial results for the period ended June 30, 2021.
The scheme incentivizes the manufacturing of patented drugs and other high value drugs at an incentive rate of 10% of incremental sales
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
India is expecting to manufacture 30-35 crore COVID-19 vaccines between July - August 2021
The company reported total income of Rs.634.79 crores during the 12 months period ended March 31, 2021
Subscribe To Our Newsletter & Stay Updated
